These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 14557644

  • 1. Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.
    Hann B, Balmain A.
    J Virol; 2003 Nov; 77(21):11588-95. PubMed ID: 14557644
    [Abstract] [Full Text] [Related]

  • 2. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.
    O'Shea CC, Johnson L, Bagus B, Choi S, Nicholas C, Shen A, Boyle L, Pandey K, Soria C, Kunich J, Shen Y, Habets G, Ginzinger D, McCormick F.
    Cancer Cell; 2004 Dec; 6(6):611-23. PubMed ID: 15607965
    [Abstract] [Full Text] [Related]

  • 3. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection.
    Goodrum FD, Ornelles DA.
    J Virol; 1998 Dec; 72(12):9479-90. PubMed ID: 9811681
    [Abstract] [Full Text] [Related]

  • 4. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.
    Shen Y, Kitzes G, Nye JA, Fattaey A, Hermiston T.
    J Virol; 2001 May; 75(9):4297-307. PubMed ID: 11287579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells.
    Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, zur Hausen H.
    J Virol; 1998 Dec; 72(12):9470-8. PubMed ID: 9811680
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).
    Ries SJ, Brandts CH, Chung AS, Biederer CH, Hann BC, Lipner EM, McCormick F, Korn WM.
    Nat Med; 2000 Oct; 6(10):1128-33. PubMed ID: 11017144
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer.
    Vasey PA, Shulman LN, Campos S, Davis J, Gore M, Johnston S, Kirn DH, O'Neill V, Siddiqui N, Seiden MV, Kaye SB.
    J Clin Oncol; 2002 Mar 15; 20(6):1562-9. PubMed ID: 11896105
    [Abstract] [Full Text] [Related]

  • 14. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene.
    Hay JG, Shapiro N, Sauthoff H, Heitner S, Phupakdi W, Rom WN.
    Hum Gene Ther; 1999 Mar 01; 10(4):579-90. PubMed ID: 10094201
    [Abstract] [Full Text] [Related]

  • 15. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.
    Roth J, König C, Wienzek S, Weigel S, Ristea S, Dobbelstein M.
    J Virol; 1998 Nov 01; 72(11):8510-6. PubMed ID: 9765388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
    Savelyeva I, Dobbelstein M.
    Oncogene; 2011 Feb 17; 30(7):865-75. PubMed ID: 20935676
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.